Exercise and rehabilitation
Reduce provocative push-off and rebuild hallux loading[1][4]
Consider when. An assessed tendon or load-related presentation without rupture, fracture or acute neural compromise.
Start with comfortable seated hallux-tip flexion against light resistance, then supported heel rises. Temporarily reduce repeated toe-pointing, sprinting or high-demand dance positions.
- Dose and review
- Illustrative entry point: a small set of slow comfortable repetitions, followed by a check of walking and next-day pain; adjust with the clinician.
- Progression
- Progress resistance and heel-rise demand before returning to repeated rapid push-off or dance extremes.
- Stop or reassess
- Stop for sharp pain, a new catch, swelling or loss of toe flexion.
- Evidence and limits
- Loading is an anatomy-informed rehabilitation choice. FHL clinical studies concern tendon disease and do not establish this dose as a muscle-MPS treatment.
Exercise and rehabilitation
Gentle excursion work for assessed FHL tendon restriction[3][4]
Consider when. A clinician identifies limited FHL glide and excludes a painful fixed joint block or acute injury.
Use gentle coordinated ankle and big-toe movement within an agreed range. The clinician may teach a specific tendon-stretch approach, keeping it below a painful catch and adapting for first-MTP symptoms.
- Dose and review
- Short, comfortable practice individualized to the examination; do not force the toe or copy a maximum stretch from an atlas.
- Progression
- Monitor excursion and the chosen push-off task rather than pursuing range for its own sake.
- Stop or reassess
- Stop for triggering, increasing forefoot pain, numbness or sustained symptom worsening.
- Evidence and limits
- Clinical cohorts report improvement with an FHL-focused nonoperative program, sometimes including immobilization; uncontrolled design and selection mean the contribution of stretching is uncertain.
Clinician-delivered care
Foot-and-ankle care for persistent mechanical tendon symptoms[3][4]
Consider when. Persistent catching, restricted excursion or disabling tendon-course pain despite an appropriate conservative program.
Reassess tendon sheath, posterior ankle and first-ray disease. A specialist can consider temporary immobilization for a markedly irritable tendon and discuss operative decompression only when a defined mechanical problem and ongoing disability justify it.
- Dose and review
- The duration of protection and any procedure plan follow the diagnosis and response; no routine injection or surgical timetable applies.
- Progression
- Review walking, toe motion and recurrence after gradual return to loading.
- Stop or reassess
- Promptly reassess progressive weakness, marked swelling, skin problems from immobilization or new neurological symptoms.
- Evidence and limits
- The 2005 series and 2021 retrospective cohort support a staged clinical pathway but do not prove comparative superiority or a universal success rate.
Clinician-delivered care
Botulinum toxin for diagnosed flexor hallucis longus spasticity[7]
Consider when. Neurological spasticity, such as after stroke, in which involuntary flexor hallucis longus activity interferes with comfortable hallux position, footwear or gait. Ordinary cramping, tendon pain and a tender point do not establish this indication.
A rehabilitation/spasticity specialist evaluates the whole limb, passive range, weakness and the role of each involved muscle. If appropriate, use guided muscle localization and pair treatment with rehabilitation or orthotic care to address comfortable hallux position, footwear or gait.
- Dose and review
- Drug selection and dose are prescribed individually. Agree on a review around 4–6 weeks and reassess before any repeat treatment.
- Progression
- Compare the agreed functional goal and adverse effects, not tone alone; a fixed contracture or weakness may need a different strategy.
- Stop or reassess
- Report new troublesome weakness or falls. Difficulty swallowing or breathing after toxin treatment requires urgent medical help.
- Evidence and limits
- The US label supports adult lower-limb spasticity. Its 468-person post-stroke trial used several muscles and followed participants for 12 weeks; benefits in ankle tone/global response at weeks 4/6 do not establish isolated-muscle pain relief or efficacy for MPS.